Improving implementation of pharmacogenetic testing in the VA healthcare system
Improving implementation of pharmacogenetic testing in the VA healthcare system
批准号:
10316792
负责人:
Corrine Ione Voils
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-01 至 2024-03-31
关键词:
AddressAdministratorAdoptedAdoptionAffectBehaviorCardiovascular systemCharacteristicsClinicalComputerized Medical RecordConsolidated Framework for Implementation ResearchCost AnalysisDataData SourcesDiseaseDoseDrug InteractionsDrug PrescriptionsEffectivenessEvaluationFutureGenesGeneticGenomic medicineGenomicsGoalsHealth BenefitHealth care facilityHealthcare SystemsIndividualInflammatoryInformaticsInfrastructureInterventionInterviewLeadershipLearningManualsMeasuresMedicaidMedicareMental HealthOutcomePainPatient ParticipationPatientsPerceptionPersonsPharmaceutical PreparationsPharmacogenomicsPharmacotherapyProviderRecommendationSiteSurveysTest ResultTestingTheoretical Domains frameworkTimeTo specifyToxic effectTypologyUnited StatesUnited States Department of Veterans AffairsVeteransVeterans Health Administrationcostcost effectiveeffectiveness evaluationgene panelhealth care deliveryimplementation determinantsimplementation facilitationimplementation processimplementation strategyimprovedmedication compliancemodel designoperationpharmacogenetic testingpoint of careprogramsprovider adoptionresponsescreeningtargeted cancer therapyuptake
中文摘要
退伍军人事务部(VA)退伍军人药物基因组测试(PHASER)计划,始于2019年,
涉及实施药物基因组学(PGx)筛选,以便患者和提供者能够访问
关注点是对影响37种常见药物处方的10个基因的PGx测试结果。的目标是
Phaser将为250,000名退伍军人提供PGx测试,以提高疗效并降低毒性和成本
与药物治疗有关。Phaser计划在#年年底达到45-50个不同的VHA医疗机构
2023年。要实现PGx检测对健康的益处,需要医疗保健领域的各种利益相关者参与
系统,包括患者、提供者和管理员。这项合作评估的目标是
加快在退伍军人管理局使用PGx测试。该项目的目标是确定实施的决定因素,
影响采用的策略和结果,以及对患者用药依从性的影响。在目标1中,我们将
在综合框架的指导下,在参与设施中与主要利益攸关方进行面谈
具体说明组织决定因素和专家建议的实施研究
实施变更类型学以确定实施战略。在AIM 2中,我们将在以下位置采访供应商
低采用率和高采用率站点,并使用回归来确定与提供商采用率相关的因素。在《目标3》中,
我们将采访已经和没有接受过PGx检测的患者,使用回归分析来确定相关因素
通过患者采用,并对进行过关于患者与提供者讨论和错过的测试的患者进行调查
剂量。最后,我们将从退伍军人管理局的角度评估实施PGx测试的成本。资料来源
包括对管理员、提供者和患者的定性访谈;由管理的Phaser计划数据
退伍军人事务部信息学和计算基础设施;以及患者调查。PASSER计划解决VA
医疗补助和医疗保险的改进和学习质量衡量标准和中心的战略分析
有意义的措施。这项评估的直接效果将是为相位器计划提供
提供可操作的信息,以优化实施过程。这一基础工作将创建一幅蓝图
促进在退伍军人事务部实施未来的基因组医学干预措施和倡议。
英文摘要
The Veterans Affairs (VA) PHarmacogenomic Testing for Veterans (PHASER) program, started in 2019,
involves implementation of pharmacogenomic (PGx) screening so that patients and providers have access at
the point of care to PGx test results of ten genes that affect prescribing of 37 common medications. The goal of
PHASER is to offer 250,000 Veterans PGx testing in order to improve efficacy and reduce toxicity and costs
related to pharmacotherapy. PHASER intends to reach 45-50 diverse VHA health care facilities by the end of
2023. Realizing the health benefits of PGx testing requires uptake by various stakeholders within a health care
system, including patients, providers, and administrators. The objective of this partnered evaluation is to
accelerate use of PGx testing in the VA. The goal of this project is to identify implementation determinants,
strategies, and outcomes that affect adoption, and effects on patient medication adherence. In Aim 1, we will
conduct interviews of key stakeholders at participating facilities, guided by the Consolidated Framework for
Implementation Research to specify organizational determinants and the Expert Recommendations for
Implementing Change typology to identify implementation strategies. In Aim 2, we will interview providers at
low- and high-adopting sites and use regression to identify factors associated with provider adoption. In Aim 3,
we will interview patients who have and have not had PGx testing, use regression to identify factors associated
with patient adoption, and survey patients who have had testing about patient-provider discussions and missed
doses. Finally, we will assess costs of implementing the PGx testing from the VA perspective. Data sources
include qualitative interviews of administrators, providers, and patients; PHASER program data managed by
the VA Informatics and Computing Infrastructure; and a patient survey. The PHASER program addresses VA
Strategic Analytics for Improvement and Learning quality measures and Centers for Medicaid and Medicare
Meaningful Measures. The immediate effect of this evaluation will be to provide the PHASER program with
actionable information to optimize implementation processes. This groundwork will create a blueprint to
facilitate implementation of future genomic medicine interventions and initiatives across the VA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collaborate2Lose: Collaborating with romantic and non-romantic support persons to improve long-term weight loss
-
批准号:10424742
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Corrine Ione Voils
-
依托单位:
(1/2) Log2Lose: Incenting weight loss and dietary self-monitoring in real-time to improve weight management
-
批准号:10054569
-
项目类别:
-
资助金额:$103.76万
-
财政年份:2020
-
负责人:Corrine Ione Voils
-
依托单位:
(1/2) Log2Lose: Incenting weight loss and dietary self-monitoring in real-time to improve weight management
-
批准号:10687915
-
项目类别:
-
资助金额:$130.56万
-
财政年份:2020
-
负责人:Corrine Ione Voils
-
依托单位:
Log2Lose: Incenting weight loss and dietary self-monitoring in real-time to improve weight management
-
批准号:10627316
-
项目类别:
-
资助金额:$8.75万
-
财政年份:2020
-
负责人:Corrine Ione Voils
-
依托单位:
Log2Lose: Incenting weight loss and dietary self-monitoring in real-time to improve weight management
-
批准号:10627319
-
项目类别:
-
资助金额:$1.61万
-
财政年份:2020
-
负责人:Corrine Ione Voils
-
依托单位:
Log2Lose: Incenting weight loss and dietary self-monitoring in real-time to improve weight management
-
批准号:10850242
-
项目类别:
-
资助金额:$9.25万
-
财政年份:2020
-
负责人:Corrine Ione Voils
-
依托单位:
(1/2) Log2Lose: Incenting weight loss and dietary self-monitoring in real-time to improve weight management
-
批准号:10274835
-
项目类别:
-
资助金额:$136.98万
-
财政年份:2020
-
负责人:Corrine Ione Voils
-
依托单位:
Using partners to enhance long-term weight loss
-
批准号:10396455
-
项目类别:
-
资助金额:$56.29万
-
财政年份:2018
-
负责人:Corrine Ione Voils
-
依托单位:
Incentivizing behavior change skills to promote weight loss
-
批准号:8967859
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2015
-
负责人:Corrine Ione Voils
-
依托单位:
Impact of family history and decision support on high-risk cancer screening
-
批准号:8940235
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Corrine Ione Voils
-
依托单位:
Impact of family history and decision support on high-risk cancer screening
-
批准号:9981437
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Corrine Ione Voils
-
依托单位:
Impact of family history and decision support on high-risk cancer screening
-
批准号:8783013
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Corrine Ione Voils
-
依托单位:
Impact of family history and decision support on high-risk cancer screening
-
批准号:10176569
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Corrine Ione Voils
-
依托单位:
Impact of family history and decision support on high-risk cancer screening
-
批准号:10178092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Corrine Ione Voils
-
依托单位:
Impact of family history and decision support on high-risk cancer screening
-
批准号:10179465
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Corrine Ione Voils
-
依托单位:
Maintenance After Initiation of Nutrition TrAINing (MAINTAIN)
-
批准号:8597290
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Corrine Ione Voils
-
依托单位:
Maintenance After Initiation of Nutrition TrAINing (MAINTAIN)
-
批准号:8199683
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Corrine Ione Voils
-
依托单位:
Improving the Detection of Medication Nonadherence
-
批准号:7990039
-
项目类别:
-
资助金额:$13.17万
-
财政年份:2010
-
负责人:Corrine Ione Voils
-
依托单位:
Developing Strategies for Maintaining Behavior Change
-
批准号:7871643
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Corrine Ione Voils
-
依托单位:
Improving the Detection of Medication Nonadherence
-
批准号:8097455
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2010
-
负责人:Corrine Ione Voils
-
依托单位:
海外基金